Apisarnthanarak Anucha, Buppunharun Wanchai, Tiengrim Surapee, Sawanpanyalert Pathom, Aswapokee Nalinee
Division of Infectious Diseases, Thammasat University Hospital, Pratumthani, Thailand.
J Med Assoc Thai. 2009 Aug;92 Suppl 4:S91-4.
The National Antimicrobial Resistance Surveillance Thailand (NARST) has been initiated since 1998 to strengthen the surveillance program for antimicrobial-resistant pathogens as well as to standardize the laboratory practices in Thailand. This collaborative network was funded by the World Health Organization, and involved 33 hospitals throughout Thailand at the first phase. Nevertheless, no prior effort has been made to share the antimicrobial resistance data in the national level. In this overview, the authors provide an update on the status of antimicrobial resistance from 2000 to 2005 among important Gram-negative pathogens as well as the implication of these findings. The most striking finding appears to be the emergence of pandrug-resistant (PDR) Acinetobacter baumannii. Carbapenem-resistant A. baumannii has been dramatically increasing from 2.1% in 2000 to 46.7% in 2005. There is a trend towards the increasing incidence rates of ESBL-producing Escherichia coli from 2000 to 2005, but the incidence rates of ESBL-producing Klebseilla pneumoniae remain constant during the same period. The susceptibility of Burkholderia pseudomallei to various antibiotics, particularly ceftazidime and carbapenems, approached 100%. In conclusions, to help strengthen the future surveillance system, NARST needs to develop the data collection tools that include some important patient characteristics and the information that can help distinguish colonizations and infections as well as community-acquired infections and hospital-acquired infections. In addition, an appropriate test for antimicrobial susceptibility including the minimal inhibitory concentration determination should be implemented and carried out for all important pathogens. The NARST data emphasized a need to strengthen the antimicrobial stewardship as well as the infection control measures at the hospital level to help reduce the transmission of antimicrobial-resistant Gram-negative bacteria in Thailand.
泰国国家抗菌药物耐药性监测(NARST)自1998年启动,旨在加强对抗菌药物耐药病原体的监测计划,并规范泰国的实验室操作。这个合作网络由世界卫生组织资助,第一阶段涉及泰国各地的33家医院。然而,此前尚未在国家层面分享抗菌药物耐药性数据。在本综述中,作者提供了2000年至2005年期间重要革兰氏阴性病原体的抗菌药物耐药性状况更新以及这些发现的意义。最引人注目的发现似乎是泛耐药鲍曼不动杆菌的出现。耐碳青霉烯鲍曼不动杆菌已从2000年的2.1%急剧增加到2005年的46.7%。2000年至2005年期间,产超广谱β-内酰胺酶大肠埃希菌的发病率呈上升趋势,但同期产超广谱β-内酰胺酶肺炎克雷伯菌的发病率保持不变。嗜麦芽窄食单胞菌对各种抗生素,特别是头孢他啶和碳青霉烯类的敏感性接近100%。总之,为帮助加强未来的监测系统,NARST需要开发数据收集工具,包括一些重要的患者特征以及有助于区分定植和感染以及社区获得性感染和医院获得性感染的信息。此外,应对所有重要病原体实施并开展包括最低抑菌浓度测定在内的适当抗菌药物敏感性检测。NARST数据强调需要加强医院层面的抗菌药物管理以及感染控制措施,以帮助减少泰国抗菌药物耐药革兰氏阴性菌的传播。